Vibrating capsule for enhancing absorption of ingested medicaments
AssigneeVibrant Corporation
InventorLior Ben-Tsur
Life of this patent
Estimating the term…
Abstract
A system and a method of using a vibrating gastrointestinal capsule in coordination with an ingestible medicament. The vibrating gastrointestinal capsule may include a housing; a vibrating agitation mechanism causing said housing to exert vibrations on an environment surrounding the vibrating gastrointestinal capsule; a power supply for powering said vibrating agitation mechanism; and a control mechanism for activating said vibrating agitation mechanism to operate in said vibration mode of operation, such that the vibration mode of operation at least partially transpires or completely transpires within an actual or estimated absorption time period of the ingestible medicament within the gastrointestinal tract of the subject.
Claims13
A kit for promoting absorption of an ingested medicament into the bloodstream of a subject, the kit comprising:
- a medicament to be ingested, said medicament being absorbable within a target region of the gastrointestinal tract, the target region being selected from the group consisting of the stomach, the small intestine, and the large intestine;
- and
- a vibrating ingestible capsule including:
- a housing;
- a vibrating agitation mechanism having a rest mode of operation and a vibration mode of operation, and adapted such that, in said vibration mode of operation, said housing exerts vibrations on an environment surrounding said vibrating gastrointestinal capsule, wherein, in said vibration mode of operation, said vibrating agitation mechanism is configured to exert said forces on said housing to attain a vibrational frequency within a range of 100 Hz to 500 Hz;
- a power supply disposed within said housing and adapted to power said vibrating agitation mechanism;
- and
- a control mechanism adapted to activate said vibrating agitation mechanism to be operative in said vibration mode of operation, said control mechanism configured to control a timing or activation delay of said vibration mode of operation such that, when the vibrating ingestible capsule is ingested by the subject, a first occurrence of said vibration mode of operation at least partially transpires in said target region of the gastrointestinal tract of the subject, within at least one of an estimated absorption time period and an actual absorption time period of said ingested medicament within said target region, so as to increase absorption of said ingested medicament into the bloodstream of the subject.
A kit for promoting absorption of an ingested medicament into the bloodstream of a subject, the kit comprising:
- a medicament to be ingested, said medicament being absorbable within a target region of the gastrointestinal tract, the target region being selected from the group consisting of the stomach, the small intestine, and the large intestine;
- and
- a vibrating ingestible capsule, physically separate from said medicament to be ingested, said vibrating ingestible capsule including:
- a housing;
- a vibrating agitation mechanism having a rest mode of operation and a vibration mode of operation, and adapted such that, in said vibration mode of operation, said housing exerts vibrations on an environment surrounding said vibrating gastrointestinal capsule, wherein, in said vibration mode of operation, said vibrating agitation mechanism is configured to exert said forces on said housing to attain a vibrational frequency within a range of 100 Hz to 500 Hz;
- a power supply disposed within said housing and adapted to power said vibrating agitation mechanism;
- and
- a control mechanism adapted to activate said vibrating agitation mechanism to be operative in said vibration mode of operation, said control mechanism configured to control a timing or activation delay of said vibration mode of operation such that, when the vibrating ingestible capsule is ingested by the subject, a first occurrence of said vibration mode of operation at least partially transpires in said target region of the gastrointestinal tract of the subject, within at least one of an estimated absorption time period and an actual absorption time period of said ingested medicament within said target region, so as to increase absorption of said ingested medicament into the bloodstream of the subject,
- wherein said vibrating agitation mechanism is adapted to be in said rest mode of operation prior to said first occurrence of said vibration mode of operation.
Dependencies are inferred from the claim text.